Strata Oncology scores $26 million for large-scale next-generation sequencing
The company plans to bring NGS to health systems lacking the ability to perform it internally.
The company plans to bring NGS to health systems lacking the ability to perform it internally.
Despite 2009 being a banner year for the business of health care, if not health care itself, just one representative from the industry makes the list.